Heating up cancer cells as they are being targeted with chemotherapy appears to be a highly effective way of killing them off.
Anticoagulant drugs that inhibit thrombin were shown to reduce the number of brain metastases in mouse models.
Researchers have identified a pathway involving a protein called Rab35 in glioblastoma brain cancer. The study reports restoring the activity of Rab35 could have therapeutic benefits for those with glioblastoma.
Researchers discovered all neuroblastomas arise from a single type of embryonic cell called sympathoblasts. The findings could lead to new avenues of treatment for the aggressive childhood cancer.
Inhibiting the SCD enzyme and blocking the function of FOSB blunts acquired drug resistance and improves survival in mouse models of glioblastoma brain cancer.
Study reveals a detailed map of gene proteins, infiltrating cells, and signaling pathways that play significant roles in the development and progression of glioblastoma brain cancer.
A new zebrafish model holds the potential for future studies of glioblastoma, an aggressive and lethal brain cancer.